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atopy but  not  asthma  in  German children. Potentially, other 
fac tors such as environmental effects may modify the role of 
 CX3CR1 polymorphisms.  Copyright © 2007 S. Karger AG, Basel 
 Introduction 
 Interleukins and chemokines are involved in the in-
duction and perpetuation of allergic immune responses. 
The chemokine CX3CL1 (fractalkine) which binds exclu-
sively to CX3CR1, a 7-transmembrane high-affinity re-
ceptor, is expressed by endothelium and epithelium. It is 
a potent mediator of monocyte migration and macro-
phage differentiation and CX3CR1 knockout mice show 
a decrease in monocyte and macrophage recruitment  [1] . 
The CX3CL1/ CX3CR1 pathway is also important in Th1 
and natural killer cell responses, as these cell types ex-
press high levels of CX3CR1 and respond to CX3CL1, 
while Th2-type cells express low levels of CX3CR1 and 
do not readily respond to CX3CL1  [2] .
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 Abstract 
 Chemokines and their receptors are involved in many as-
pects of immunity. Chemokine CX3CL1, acting via its recep-
tor CX3CR1, regulates monocyte migration and macrophage 
differentiation as well as T cell-dependent inflammation. 
Two common, nonsynonymous polymorphisms in  CX3CR1 
have previously been shown to alter the function of the 
CX3CL1/CX3CR1 pathway and were suggested to modify the 
risk for asthma. Using matrix-assisted laser desorption/ion-
ization time-of-flight technology, we genotyped polymor-
phisms Val249Ile and Thr280Met in a cross-sectional popula-
tion of German children from Munich (n = 1,159) and Dresden 
(n = 1,940). For 249Ile an odds ratio of 0.77 (95% confidence 
interval 0.63–0.96; p = 0.017) and for 280Met an odds ratio of 
0.71 (95% confidence interval 0.56–0.89; p = 0.004) were 
found with atopy in Dresden but not in Munich. Neither 
polymorphism was associated with asthma. Thus, amino 
acid changes in CX3CR1 may influence the development of 
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 Thus, it was suggested that the CX3CL1/ CX3CR1 
pathway serves as an amplification circuit for polarized 
Th1 responses. Alternatively, CX3CR1-dependent pro-
cesses may also regulate immunological tolerance and in-
flammation by controlling interactions of dendritic cells 
with pathogens  [3] .
 In the airways, CX3CL1 is produced by smooth mus-
cle cells. In asthmatics, CX3CL1 levels are upregulated 
and CX3CR1 function is increased in peripheral CD4+ T 
lymphocytes recruited to the airways after allergen stim-
ulation  [4] . In contrast, baseline expression of CX3CR1 is 
decreased in the airways of asthmatics compared to 
healthy controls  [5] . In the case of bronchial inflamma-
tion, CX3CL1 levels seem to correlate positively with 
mononuclear cell counts in bronchoalveolar lavage  [6] .
 Common  CX3CR1 polymorphisms leading to amino 
acid changes (Val249Ile and Thr280Met) were previously 
identified and result in decreased receptor expression, re-
duced receptor function and diminished ligand affinity 
 [7] . Although both variants responded similarly to solu-
ble CX3CL1  [8] , 249Ile was also associated with enhanced 
adhesiveness  [9] . These functional polymorphisms were 
recently proposed to protect from asthma, while no effect 
on atopy was found  [10] . We investigated the role of both 
functional polymorphisms in atopy and asthma in 2 
cross-sectional German populations of 9- to 11-year-old 
children from West (Munich n = 1,159) and East Ger-
many (Dresden n = 1,940).
 Material and Methods 
 As described previously  [11] , 3,099 German children (9–11 
years) recruited from Munich and Dresden in the cross-sectional 
International Study on Asthma and Allergy in Childhood (ISAAC 
II) were phenotyped for a doctor’s diagnosis of asthma, hay fever 
and atopic dermatitis by questionnaire, for atopy by skin prick 
testing, as well as total and specific serum IgE tests against aero-
allergens  (Sx1) and food allergens  (Fx5) (Pharmacia, Freiburg, 
Germany). Informed written consent was obtained from the par-
ents of children included in the study. All study methods were 
approved by the local ethics committees.
 Genomic DNA was extracted from whole blood by a standard 
salting out method and for genotyping, matrix-assisted laser de-
sorption/ionization time-of-flight mass spectrometry was ap-
plied as described in detail elsewhere  [12] using primers (Seque-
nom, San Diego, Calif., USA) shown in  table 1 .
 Deviation from Hardy-Weinberg equilibrium was analyzed 
with    2  tests. Association between single nucleotide polymor-
phisms and dichotomous outcomes were evaluated using    2  tests 
in a dominant model of the rare allele. All statistical tests were 
two-sided and a nominal level of significance (  = 0.05) was used. 
Calculations were carried out with SAS (version 9.1.3) and SAS/
Genetics.
 Results 
 Genotyping was successful in 97.8% and 98.5% of
samples for Val249Ile and Thr280Met, respectively, and 
both single nucleotide polymorphisms did not deviate 
from Hardy-Weinberg equilibrium ( table 1 ). In the Dres-
den population, 249Ile and 280Met significantly decreased 
the risk to develop atopy ( table 2 ). In addition, carriers of 
the 280Met allele were less likely to show significantly el-
evated serum IgE levels (above the 66th and 90th percen-
tile of the German reference population of this age, equiv-
alent to 115 and 457 IU/ml, respectively). When the asso-
ciation between polymorphisms and increased specific 
serum IgE against either inhalant  (Sx1) or food allergens 
 (Fx5) was analyzed, 249Ile and 280Met were protective 
against sensitization to aeroallergens but not food aller-
gens. However, no such effects were observed in the Mu-
nich population. In addition, no association was found 
between polymorphisms in  CX3CR1 and the develop-
ment of atopic dermatitis, hay fever and asthma neither in 
Dresden nor in Munich (data not shown).
Table 1. Description of the investigated CX3CR1 single nucleotide polymorphisms and primers used for matrix-assisted laser desorp-
tion/ionization time-of-flight mass spectrometry
SNP rs No. Alleles p value (test
for deviation
of HWE)
Minor allele
frequency
PCR primer Extension primer
CX3CR1
Val249Ile
rs3732379 G/A 0.622 0.27 1st ACGTTGGATGTAGAGCTTAAGCGTCTCCAG
2nd ACGTTGGATGTGATCCTTCTGGTGGTCATC
CTTCTGGACACC-
CTACAAC
CX3CR1
Thr280Met
rs3732378 C/T 0.605 0.17 1st ACGTTGGATGGATGAGAGGATTCAGGCAAC
2nd ACGTTGGATGACATGAGGAAGGATCTGAGG
CCTCAGTGTGAC-
TGAGA
SNP = Single nucleotide polymorphism; HWE = Hardy-Weinberg equilibrium; PCR = polymerase chain reaction.
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 Discussion 
 An inverse association between the  CX3CR1 polymor-
phisms 249Ile and 280Met and atopic sensitization was 
only present in children from Dresden. This association 
could be spurious but could alternatively be explained by 
 CX3CR1 interactions with different environmental fac-
tors in both study populations. Notably, children from 
Dresden spent their first 3 years of life in the former Ger-
man Democratic Republic, exposed to very different life-
style factors (e.g. higher number of siblings, early day 
care, different outdoor pollutants, pet keeping) which 
were previously associated with the development of or the 
protection against asthma and atopy  [11, 13] . These envi-
ronmental effects may act through gene-by-environment 
interactions as shown previously for other genes  [14] . The 
results of this study may only be a fist hint towards a pos-
sible role of  CX3CR1  polymorphisms in such interac-
tions, which have not yet been elucidated further.
 No protective effect was observed for asthma, which 
could have been expected based on previous association 
studies  [10] . Thus, the discrepancy in results between at-
opy and asthma observed with  CX3CR1 polymorphisms 
may reflect some differences in pathomechanisms be-
tween asthma and atopy, and the functional impact of 
CX3CR1 variants in atopy may involve a delicate balance 
between excessive adhesion and chemotaxis. According-
ly, our results may indicate that CX3CR1 is more involved 
in immunological mechanisms of atopic sensitization 
than the induction of a lung-specific atopic inflamma-
tion.
 This study did not aim at performing a systematic and 
comprehensive study of the whole CX3CR1 gene locus. 
Rather, amino acid changes leading to clearly character-
ized functional changes which were previously reported 
to be involved in other diseases were studied for their role 
in atopy and atopic diseases. Thus, it cannot be excluded 
that further polymorphisms in and around the CX3CR1 
249Ile 280Met
Atopy
(≥3mm SPT)
Munich 0.91 (0.69–1.22)
p = 0.539
0.99 (0.73–1.34)
p = 0.932
Dresden 0.77 (0.63–0.96)
p = 0.017
0.71 (0.56–0.89)
p = 0.004
Total IgE
66th percentile
(≥115 IU/ml)
Munich 0.92 (0.71–1.19)
p = 0.528
0.90 (0.68–1.19)
p = 0.443
Dresden 0.88 (0.73–1.07)
p = 0.200
0.81 (0.66–1.00)
p = 0.050
90th percentile
(≥457 IU/ml)
Munich 0.83 (0.55–1.24)
p = 0.356
0.85 (0.55–1.32)
p = 0.478
Dresden 0.76 (0.57–1.03)
p = 0.080
0.69 (0.49–0.97)
p = 0.031
Specific IgE
Aeroallergens, Sx1
(≥rast3)
Munich 0.96 (0.73–1.26)
p = 0.758
1.08 (0.80–1.45)
p = 0.612
Dresden 0.73 (0.59–0.92)
p = 0.006
0.70 (0.55–0.90)
p = 0.005
Food allergens, Fx5
(≥rast3)
Munich 0.73 (0.26–2.03)
p = 0.542
0.76 (0.24–2.39)
p = 0.634
Dresden 1.11 (0.49–2.52)
p = 0.799
1.37 (0.58–3.26)
p = 0.476
Odds ratios and 95% confidence intervals in parentheses are shown for the associa-
tion between CX3CR1 polymorphisms and atopy measured by skin prick test, total se-
rum IgE percentiles and specific serum IgE against inhalative (Sx1) and food (Fx5) al-
lergens in Munich (n = 1,159) and Dresden (n = 1,940). In Dresden, 25.4% (n = 493) of 
the children showed a positive reaction in skin prick testing and 24.5% (n = 284) in Mu-
nich.
Table 2. Association between CX3CR1 
polymorphisms and atopy defined by 
skin prick test, and total and specific 
serum IgE measurements in populations 
from Munich and Dresden
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gene may contribute to the development of atopic diseas-
es as suggested by others  [10] .
 In conclusion, this study suggests that CX3CR1 poly-
morphisms show variable associations with atopy and 
asthma in different populations. If these discrepancies 
are attributable to chance only or if these inconsistencies 
are due to cofactors such as gene-by-gene or gene-by-en-
vironment interactions, needs further evaluation.
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